APA (7th ed.) Citation

S, Q. (2022). TNFR2 antagonist and agonist: A potential therapeutics in cancer immunotherapy. Medical oncology (Northwood, London, England), 39(12), 215. https://doi.org/10.1007/s12032-022-01772-2

Chicago Style (17th ed.) Citation

S, Quazi. "TNFR2 Antagonist and Agonist: A Potential Therapeutics in Cancer Immunotherapy." Medical Oncology (Northwood, London, England) 39, no. 12 (2022): 215. https://doi.org/10.1007/s12032-022-01772-2.

MLA (9th ed.) Citation

S, Quazi. "TNFR2 Antagonist and Agonist: A Potential Therapeutics in Cancer Immunotherapy." Medical Oncology (Northwood, London, England), vol. 39, no. 12, 2022, p. 215, https://doi.org/10.1007/s12032-022-01772-2.